RSI Chief Medical Officer, Dr. Donald R. Mattison, in collaboration with colleagues from the Institute for Safe Medication Practices and Wake Forest University, evaluated and compared the safety profiles of newer contraceptives using 43,324 adverse event case reports submitted to the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS), for the two years ending July 2017. The presentation on Saturday, March 10, 2018 in San Diego described the strong safety profiles of the newer contraceptives, as well as issues of concern.
For more details see the presentation poster here.
More RSI News
RSI speaks to The Weather Network about wildfires and climate
2017 was a record-setting year for devastating wildfires across Canada and throughout the world. The Weather Network spoke to Heather Auld, principal climate scientist about…
RSI paper on Manganese PBPK selected as a top 2017 paper
Each year the Society of Toxicology, Biological Modeling Specialty Section (BMSS) does a literature search to identify outstanding modeling papers in the field of toxicology.…
RSI and Engineers Canada develop on-line training courses
Engineers Canada has retained Risk Sciences International’s (RSI) Climate Group to develop training course modules and to deliver on-line training to Professional Engineers seeking to…
Roger Rempel joins RSI as Director of Climate Group
RSI is pleased to announce that Roger Rempel has joined us as the Director of the RSI Climate Group. Roger is a senior environmental engineer…